In this study, we performed immunohistochemistry analysis to examine the expression of SATB1 in clinical prostatic carcinoma samples and analyze the correlation of SATB1 expression with the clinicopathological features of prostate cancer. This evidence concerns the gene SATB1 and prostate cancer.